440 results on '"Shahabi, Shohreh"'
Search Results
2. Association of chemotherapy and radiotherapy sequence with overall survival in locoregionally advanced endometrial cancer
3. Supplemental Methods from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
4. Table S3 from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
5. Figure S1. Adjusted survival curves for the matched NCDB and SEER cohorts. from 21-Gene Recurrence Score Assay Predicts Benefit of Post-Mastectomy Radiotherapy in T1-2 N1 Breast Cancer
6. Supplementary Table 2 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
7. Supplementary Table 4 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
8. Supplementary Figure 2 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
9. Supplementary Figure 3 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
10. Supplementary Figure 1 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
11. Supplementary Table 1 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
12. Supplementary Table 3 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
13. Supplementary Figure 2 from HuR Regulates β-Tubulin Isotype Expression in Ovarian Cancer
14. Supplementary Figure 1 from HuR Regulates β-Tubulin Isotype Expression in Ovarian Cancer
15. Data from HuR Regulates β-Tubulin Isotype Expression in Ovarian Cancer
16. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study
17. The Hispanic Paradox in endometrial cancer: A National Cancer Database study
18. Ovarian granulosa cell tumor: A National Cancer Database study
19. Cost-effectiveness analysis of dose-dense versus standard intravenous chemotherapy for ovarian cancer: An economic analysis of results from the Gynecologic Oncology Group protocol 262 randomized controlled trial
20. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study
21. Stage I uterine carcinosarcoma: Matched cohort analyses for lymphadenectomy, chemotherapy, and brachytherapy
22. Chemotherapy delay after primary debulking surgery for ovarian cancer
23. Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials
24. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study
25. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study
26. Macrogenomic engineering via modulation of the scaling of chromatin packing density
27. Surgical wait time: A new health indicator in women with endometrial cancer
28. The impact of international economic sanctions on Iranian cancer healthcare
29. Prognosis and treatment of positive peritoneal cytology in early endometrial cancer: matched cohort analyses from the National Cancer Database
30. Discussing sarcoma risks during informed consent for nonhysterectomy management of fibroids: an unmet need
31. Survival After Minimally Invasive Radical Hysterectomy for Early-stage Cervical Cancer
32. TP53 hot spot mutations in ovarian cancer: Selective resistance to microtubule stabilizers in vitro and differential survival outcomes from The Cancer Genome Atlas
33. Survival After Primary Debulking Surgery Compared With Neoadjuvant Chemotherapy in Advanced Ovarian Cancer: A National Cancer Database Study
34. Survival After Pelvic Exenteration for Cervical Cancer: A National Cancer Database Study
35. Feasibility, Sensitivity, and Specificity of Postprocedure Peritoneal Cytology
36. Role of Elevated Cancer Antigen 19-9 in Women With Mature Cystic Teratoma
37. Epothilone B enhances Class I HLA and HLA-A2 surface molecule expression in ovarian cancer cells
38. Efficacy and safety of tivozanib in recurrent, platinum-resistant ovarian, fallopian tube or primary peritoneal cancer, an NCCN phase II trial
39. Epothilone B enhances surface EpCAM expression in ovarian cancer Hey cells
40. International sanctions: Sanctions in Iran disrupt cancer care
41. The Clinical Relevance of Rising CA-125 Levels Within the Normal Range in Patients With Uterine Papillary Serous Cancer
42. Exploring Novel Precision Medicine Approaches in High Grade Serous Ovarian Cancer
43. Scope of Global Health Training in U.S. Obstetrics and Gynecology Residency Programs
44. Liver metastasis in a case of adenoid cystic carcinoma of the Bartholin’s gland: a rare presentation
45. Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors
46. Gli family transcription factors are drivers of patupilone resistance in ovarian cancer
47. Abstract A36: Developing a novel treatment for advanced ovarian cancer by targeting the c-Met pathway
48. Feasibility and Preliminary Efficacy of a Bright Light Intervention in Ovarian and Endometrial Cancer Survivors
49. Platform-Independent Classification System to Predict Molecular Subtypes of High-Grade Serous Ovarian Carcinoma
50. The comprehensive midtrimester test: High-sensitivity down syndrome test
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.